Intelligence Search Intelligence Filter by: Industry Team Airport & AviationAutomotiveEmerging TechnologiesEnergy Food & BeverageHealth CareHospitality, Resort & GolfInsurance & Reinsurance Life SciencesMedical DevicesSports Practice Area Business Law All Business LawEmployee Benefits & Executive CompensationEnvironmental RegulationEstates & TrustsFinance & Financial InstitutionsHealth Care Finance Private Equity & Venture CapitalPublic FinanceReal EstateSecurities, Commodities & Exchange RegulationTaxationTransactional & Securities Government & Public Policy All Government & Public PolicyFDA RegulatoryGovernment ProcurementImmigration, Nationality & Consular Law NHTSA & Motor Vehicle SafetyPolitical LawPublic PolicySurface Transport Intellectual Property All Intellectual PropertyBusiness Method & Software PatentsChemical, Biotechnology & PharmaceuticalElectronicsGreen Energy TechnologiesInformation Technology & Outsourcing IP Due DiligenceIP LitigationMechanical & Electromechanical TechnologiesPatent Office TrialsTrademark, Copyright & Advertising Counseling International All InternationalChina EuropeJapan Litigation All LitigationAntitrustAppellateBankruptcy & Business ReorganizationsBusiness Litigation & Dispute ResolutionConstructionConsumer Financial Services Distribution & FranchiseGovernment Enforcement, Compliance & White Collar DefenseInsurance & Reinsurance LitigationLabor & EmploymentPrivacy, Security & Information ManagementSecurities Enforcement & LitigationTrade Secret Noncompete Litigation Topic Accountable Care OrganizationsAmerica Invents Act (Patent Reform)Consumer Protection Act Corporate GovernanceDodd–Frank Wall Street ReformExport Control/Economic Sanctions Foreign Corrupt Practices Act (FCPA)Health Care ReformPersonalized Medicine Type ArticleBlog Post BookNewsletter VideoWhite Paper Featured All Filters applied: Search phrase entered: Sort results by: Most Recent Most Viewed Most Shared Foley Blogs: CFSL Bulletin Cleantech & Nano Dashboard Insights Labor & Employment Law Perspectives Personalized Medicine Bulletin PharmaPatents Renewable Energy Outlook Wisconsin Appellate Law previous23456next Maximizing the Effect of Patent Applications as Prior Art Under the AIA 21 February 2013 PharmaPatents Now that we are less than one month away from implementation of the First-Inventor-To-File provisions of the America Invents Act (AIA), stakeholders are considering... A First Look at the Final First Inventor to File Rules 19 February 2013 PharmaPatents The USPTO’s final First Inventor To File rules and Examination Guidelines were published in the February 14, 2013 edition of the Federal Register. While many of... USPTO Considers Best Practices to Improve Patent Application Quality 14 February 2013 PharmaPatents In a Federal Register Notice published January, 13, 2013, the USPTO asks the public to consider potential best practices aimed at improving patent application quality ”in... International Harmonization of Patent Laws 12 February 2013 PharmaPatents The USPTO and other patent offices around the world are studying the feasibility of the international harmonization of patent laws. As part of this initiative, the... Oral Argument in CLS Bank: Redefining Patent Eligibility for Computer-Related Inventions? 11 February 2013 Legal News Alert: Intellectual Property On February 8, 2013, the Federal Circuit, sitting en banc, heard oral arguments in CLS Bank International v. Alice Corporation Pty. Ltd., No. 2011-1301, which vacated... A Look at the Technical Amendments to the America Invents Act (AIA) Made by HR 6621 07 February 2013 PharmaPatents On January 14, 2013, President Obama signed HR 6621 into law. The title of HR 6621 is “To correct and improve certain provisions of the Leahy-Smith America Invents... USPTO Board Holds That Complaint Dismissed Without Prejudice Does Not Bar Inter Partes Review 05 February 2013 PharmaPatents In a decision granting (in part) a Request for Inter Partes Review, the USPTO Patent Trial and Appeal Board (PTAB) held that an infringement complaint that was dismissed... Taking a Stand on USPTO Request for Continued Examination (RCE) Policy 31 January 2013 PharmaPatents Next week (February 4, 2013) is the deadline for submitting comments in response to the USPTO’s request for feedback on Request for Continued Examination (RCE) practice.... The Patent Term Adjustment Pendulum Swings the Other Way 29 January 2013 PharmaPatents On January 28, 2012, Judge Brinkema of the U.S. District Court for the Eastern District of Virginia issued a decision in a different Exelixis v. Kappos Patent Term... Maximizing Patent Term Adjustment Under Exelixis 24 January 2013 PharmaPatents A number of Patent Term Adjustment (PTA) cases have been filed in the U.S. District Court for the Eastern District of Virginia since the November 1, 2012 decision... previous23456next Related 1 2 3
Maximizing the Effect of Patent Applications as Prior Art Under the AIA 21 February 2013 PharmaPatents Now that we are less than one month away from implementation of the First-Inventor-To-File provisions of the America Invents Act (AIA), stakeholders are considering...
A First Look at the Final First Inventor to File Rules 19 February 2013 PharmaPatents The USPTO’s final First Inventor To File rules and Examination Guidelines were published in the February 14, 2013 edition of the Federal Register. While many of...
USPTO Considers Best Practices to Improve Patent Application Quality 14 February 2013 PharmaPatents In a Federal Register Notice published January, 13, 2013, the USPTO asks the public to consider potential best practices aimed at improving patent application quality ”in...
International Harmonization of Patent Laws 12 February 2013 PharmaPatents The USPTO and other patent offices around the world are studying the feasibility of the international harmonization of patent laws. As part of this initiative, the...
Oral Argument in CLS Bank: Redefining Patent Eligibility for Computer-Related Inventions? 11 February 2013 Legal News Alert: Intellectual Property On February 8, 2013, the Federal Circuit, sitting en banc, heard oral arguments in CLS Bank International v. Alice Corporation Pty. Ltd., No. 2011-1301, which vacated...
A Look at the Technical Amendments to the America Invents Act (AIA) Made by HR 6621 07 February 2013 PharmaPatents On January 14, 2013, President Obama signed HR 6621 into law. The title of HR 6621 is “To correct and improve certain provisions of the Leahy-Smith America Invents...
USPTO Board Holds That Complaint Dismissed Without Prejudice Does Not Bar Inter Partes Review 05 February 2013 PharmaPatents In a decision granting (in part) a Request for Inter Partes Review, the USPTO Patent Trial and Appeal Board (PTAB) held that an infringement complaint that was dismissed...
Taking a Stand on USPTO Request for Continued Examination (RCE) Policy 31 January 2013 PharmaPatents Next week (February 4, 2013) is the deadline for submitting comments in response to the USPTO’s request for feedback on Request for Continued Examination (RCE) practice....
The Patent Term Adjustment Pendulum Swings the Other Way 29 January 2013 PharmaPatents On January 28, 2012, Judge Brinkema of the U.S. District Court for the Eastern District of Virginia issued a decision in a different Exelixis v. Kappos Patent Term...
Maximizing Patent Term Adjustment Under Exelixis 24 January 2013 PharmaPatents A number of Patent Term Adjustment (PTA) cases have been filed in the U.S. District Court for the Eastern District of Virginia since the November 1, 2012 decision...